These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 31303533

  • 1. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Shen A, Liu M, Zheng D, Chen Q, Wu Z.
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH, Zhang XP, Zhou TF, Wang K, Wang H, Chai ZT, Shi J, Guo WX, Cheng SQ.
    Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX.
    World J Gastroenterol; 2017 Nov 07; 23(41):7415-7424. PubMed ID: 29151695
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion.
    Qi YP, Zhong JH, Liang ZY, Zhang J, Chen B, Chen CZ, Li LQ, Xiang BD.
    Am J Surg; 2019 Apr 07; 217(4):739-744. PubMed ID: 30103903
    [Abstract] [Full Text] [Related]

  • 7. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
    Luo L, Shan R, Cui L, Wu Z, Qian J, Tu S, Zhang W, Xiong Y, Lin W, Tang H, Zhang Y, Zhu J, Huang Z, Li Z, Mao S, Li H, Hu Z, Peng P, He K, Li Y, Liu L, Shen W, He Y.
    United European Gastroenterol J; 2023 Mar 07; 11(2):228-241. PubMed ID: 36905230
    [Abstract] [Full Text] [Related]

  • 8. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X, Liu L, Wang D, Li H, Su C, Guo X.
    Oncotarget; 2015 Nov 03; 6(34):36838-59. PubMed ID: 26451613
    [Abstract] [Full Text] [Related]

  • 9. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
    Liu S, Li H, Guo L, Zhang B, Zhou B, Zhang W, Zhou J, Fan J, Ye Q.
    Oncologist; 2019 Apr 03; 24(4):513-520. PubMed ID: 30552155
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
    Zeng G, Zou B, Li Y, Lin E, Liu X, Li P, Chen J, Zhang B, Jia Y, Cai C, Li J.
    J Invest Surg; 2022 Jun 03; 35(6):1208-1216. PubMed ID: 35078386
    [Abstract] [Full Text] [Related]

  • 11. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y, Lin K, Liu L, Qian Y, Yang Y, Yuan S, Zhu P, Huang J, Liu F, Gu F, Fu S, Jiang B, Liu H, Pan Z, Lau WY, Zhou W.
    Cancer Med; 2021 Mar 03; 10(6):2100-2111. PubMed ID: 33650288
    [Abstract] [Full Text] [Related]

  • 12. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z, Chen S, Xiao H, Wang Y, Li J, Mei J, Chen Z, Zhou Q, Feng S, Chen M, Qian G, Peng S, Kuang M.
    Radiology; 2019 Jul 03; 292(1):237-247. PubMed ID: 31135299
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR, Tian MX, Tao CY, Tang Z, Zhou YF, Song SS, Jiang XF, Wang H, Zhou PY, Qu WF, Fang Y, Ding ZB, Zhou J, Fan J, Shi YH.
    BMC Cancer; 2020 Jul 10; 20(1):642. PubMed ID: 32650743
    [Abstract] [Full Text] [Related]

  • 14. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
    Chen W, Ma T, Zhang J, Zhang X, Chen W, Shen Y, Bai X, Liang T.
    HPB (Oxford); 2020 Jun 10; 22(6):795-808. PubMed ID: 31980307
    [Abstract] [Full Text] [Related]

  • 15. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
    Xiang C, Shen X, Zeng X, Zhang Y, Ma Z, Zhang G, Song X, Huang T, Yang J.
    Int J Surg; 2024 Jan 01; 110(1):315-323. PubMed ID: 37812183
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
    Feng X, Feng GY, Tao J, Ao YP, Wu XH, Qi SG, Shi ZR.
    J Cancer Res Clin Oncol; 2023 Sep 01; 149(12):10505-10518. PubMed ID: 37284841
    [Abstract] [Full Text] [Related]

  • 18. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
    Wang YY, Wang LJ, Xu D, Liu M, Wang HW, Wang K, Zhu X, Xing BC.
    HPB (Oxford); 2019 Apr 01; 21(4):425-433. PubMed ID: 30249510
    [Abstract] [Full Text] [Related]

  • 19. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J, Liang H, Hu K, Xiong Z, Cao M, Zhong Z, Yao Z, Deng M.
    Cancer Cell Int; 2021 Feb 06; 21(1):92. PubMed ID: 33549093
    [Abstract] [Full Text] [Related]

  • 20. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL, Xiao H, Xie ZL, Shen JX, Chen ZB, Wang YQ, Li B, Peng ZW, Kuang M, Lai JM, Peng S.
    Eur Radiol; 2020 Jun 06; 30(6):3473-3485. PubMed ID: 32048035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.